VACCINE

Vaccine • August 2011
Letter to the Editor
Aluminium-based adjuvants should not be used as placebos in clinical trials
by Christopher Exley
The Birchall Centre, Lennard-Jones Laboratories, Keele University, Staffordshire, UK
August 2011
Report available for purchase $39.95
http://www.ncbi.nlm.nih.gov/pubmed/?term=21871940
[Vaccine manufacturers use aluminum-based adjuvants with controls
in clinical trials meaning adverse affects of aluminum will go unnoticed]